tiprankstipranks
Kura Oncology (KURA)
NASDAQ:KURA

Kura Oncology (KURA) Financial Statements

443 Followers

Kura Oncology Financial Overview

Kura Oncology's market cap is currently ―. The company's EPS TTM is $-2.083; its P/E ratio is -9.80; Kura Oncology is scheduled to report earnings on May 7, 2024, and the estimated EPS forecast is $-0.55. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue----$ 0.00
Gross Profit-----
EBIT$ -38.20M$ -36.79M$ -31.57M$ -27.53M$ -35.50M
EBITDA$ -40.75M$ -38.56M$ -32.94M$ -27.94M$ -35.31M
Net Income Common Stockholders$ -38.60M$ -37.17M$ -31.93M$ -31.73M$ -35.50M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 452.59M$ 476.98M$ 405.90M$ 437.99M$ 427.77M
Total Assets$ 473.77M$ 494.74M$ 423.61M$ 456.31M$ 447.99M
Total Debt$ 17.42M$ 13.04M$ 13.54M$ 14.02M$ 5.38M
Net Debt$ -435.17M$ -463.94M$ -392.36M$ -423.96M$ -422.39M
Total Liabilities$ 43.83M$ 35.06M$ 30.79M$ 36.03M$ 28.37M
Stockholders Equity$ 429.94M$ 459.68M$ 395.18M$ 420.28M$ 419.62M
Cash Flow-
Free Cash Flow$ -29.05M$ -25.71M$ -35.91M$ -26.54M$ -21.39M
Operating Cash Flow$ -29.03M$ -25.62M$ -35.87M$ -26.53M$ -21.01M
Investing Cash Flow$ 8.56M$ -46.33M$ 11.13M$ -47.32M$ 71.81M
Financing Cash Flow$ 84.00K$ 94.01M-$ 34.71M$ 880.00K
Currency in USD

Kura Oncology Earnings and Revenue History

Kura Oncology Debt to Assets

Kura Oncology Cash Flow

Kura Oncology Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis